Jump to any asset
849 assets, updated daily
As of September 26, 2026, Salesforce, Inc. (CRM) trades at $234.02. CleaRank Financial AI rates it Buy with a fair value of $285.00, 21.8% above the current price. Wall Street's consensus target is $285.00 across 55 analysts. RSI at 31 is in neutral territory, and the price is above its 50-day average of $213.68.
Salesforce, Inc. (CRM)
Salesforce, Inc. NYSE
$234.02
-4.200 (-1.76%)
At close: Sep 25, 4:00 PM EDT
AI Analyst Consensus
69 / 100
Salesforce, Inc. (CRM) is currently trading at $234.02, below its 20-day EMA but above its 50-day and 200-day moving averages ($213.68 and $201.26), indicating a mixed short-term technical picture with longer-term support. The company has demonstrated a strong track record of earnings beats, most recently reporting an EPS of $5.90 for the quarter ending September 2026, significantly exceeding the estimate of $3.27 and driving a 22.58% price increase. This consistent outperformance, coupled with positive revenue growth estimates, underpins a favorable fundamental outlook. However, significant insider selling, with total sales of $95.9 million against $28.4 million in purchases, presents a notable risk that investors should closely observe.
CRM Price Analysis
Market Metrics
Open
$237.03
Day Range
$233.38 to $239.37
Prev Close
$238.22
Volume
8.74M
52-Week Range
$146.32 to $269.11
Market Cap
$192.60B
Peer Benchmarking
Valuation vs Sector (Technology)
Performance vs XLK
Sector Position Analysis
Trading at a notable discount to sector peers (-37%), which may indicate undervaluation or specific company headwinds.
CRM Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 5 quarters, CRM beat estimates 5 times. The stock rose 3 times the next day. Price tends to react positively to beats.
CRM Analysis
Company's Health
4/5
12-Month Analyst Target
+21.78% Upside
Median of 55 analysts (12-month)
$285.00
AI Technical Analysis
Salesforce, Inc. (CRM) is currently trading below its 20-day EMA of $237.98, suggesting near-term weakness, but remains above its 50-day SMA of $213.68 and 200-day SMA of $201.26, indicating a longer-term uptrend. The Relative Strength Index (RSI) at 31.45 signals bearish momentum, reinforcing the short-term caution. Key support levels are found at the 50-day SMA ($213.68) and 200-day SMA ($201.26), while resistance may emerge near the 20-day EMA ($237.98). Volume has been below average recently, suggesting a lack of strong conviction in the current price action.
ProTips
- Monitor insider transaction activity closely, as the recent heavy selling pressure from insiders warrants caution despite positive analyst ratings.
- The stock is trading below its 20-day EMA, suggesting potential near-term weakness; consider waiting for a confirmed break above this level for a more favorable entry point.
- Given the strong earnings beats, consider dollar-cost averaging into a position to mitigate short-term volatility risk.
Key Catalysts
Bearish
Significant Insider Selling Pressure
Insiders have sold $95.9 million worth of CRM stock against $28.4 million in purchases, indicating potential concerns or profit-taking among management.
Source: Insider TransactionsBullish
Strong Earnings Beat in Q3 2026
Salesforce reported an EPS of $5.90, significantly exceeding estimates and driving a 22.58% stock price increase, highlighting operational strength.
Source: Company Earnings ReportBullish
Positive Analyst Sentiment and Price Targets
The median analyst price target of $285.00 suggests a 21.8% upside potential, with a 'Buy' consensus from 55 analysts.
Source: Wall Street AnalystsNeutral
Continued Revenue Growth Projections
Revenue is projected to grow by 12.00% in the current quarter and 11.00% in the current year, indicating sustained business expansion.
Source: Wall Street EstimatesMarket Outlook
The base case scenario for Salesforce, Inc. (CRM) anticipates continued growth supported by strong earnings performance and positive analyst sentiment, with a median price target of $285.00 suggesting a 21.8% upside from current levels. Potential catalysts for upside include further strong earnings beats and successful integration of new product offerings. Conversely, sustained heavy insider selling or increased competitive pressure could lead to a downside scenario, potentially testing support levels around the 50-day SMA of $213.68.
Key Statistics
| Market Cap | 192.60B |
|---|---|
| P/E Ratio | 21.41 |
| EPS (TTM) | 10.93 |
| Dividend Yield | 0.74% |
| 52 Week High | 269.11 |
| 52 Week Low | 146.32 |
Salesforce, Inc. (CRM) trades at a Price-to-Earnings (P/E) ratio of 21.41, which is below the Technology sector median of 34, suggesting a potential valuation discount relative to peers. The company boasts a strong profit margin of 21.99% and an operating margin of 21.38%, indicating efficient operations. Its return on equity stands at a healthy 19.38%, surpassing the sector average of 13.4%. The debt-to-equity ratio of 1.10 is in line with the sector average, suggesting a manageable debt load. These fundamentals support the current valuation, although the recent insider selling warrants attention.
Earnings & Growth Analysis
Salesforce, Inc. (CRM) delivered a substantial earnings beat in its most recent quarter ending September 2026, reporting an EPS of $5.90 against an estimate of $3.27, a surprise of 80.43%, which propelled the stock price up by 22.58%. This follows a pattern of positive earnings surprises, with the company also beating estimates in the prior two reported quarters. Revenue growth is projected to be around 12.00% for the current quarter and 11.00% for the current year, indicating continued expansion.
Key Risks
Significant insider selling, with total sales of $95.9 million versus $28.4 million in purchases, presents a key risk, suggesting a potential lack of confidence from management despite strong earnings. While the stock is trading above key long-term moving averages, the bearish RSI momentum indicates potential for further downside in the short term. Competitive pressures within the software application sector also pose an ongoing challenge.
Technical Indicators
| RSI (14) | 31.45 |
|---|---|
| MACD | 5.60 |
| SMA 50 | 213.68 |
| SMA 200 | 201.26 |
RSI
Bearish
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($213.68) above the 200-day SMA ($201.26), price action is firmly bullish above key moving averages.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.38
Weak correlation
Nasdaq 100 (QQQ)
+0.33
Weak correlation
Bitcoin (BTC)
+0.17
Weak correlation
Gold (XAU)
-0.06
Weak correlation
Check Custom Correlation
How does any other asset move with CRM? One year of daily closes, Pearson correlation.
Try
CRM Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Long entry pick an entry style
Conservative
$229.34
2% below current price (Pullback entry)
Lower risk, wait for pullback
Aggressive
$234.02
Buy at current price
Higher risk, immediate entry
Risk Management
STOP LOSS
$213.29
MAX LOSS
-7.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (31.5) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$240.81
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$252.27
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$263.74
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
High-Volatility Risk Disclaimer
CRM is classified as a high-volatility asset (Daily Vol: 4.66%). Aggressive price swings can lead to rapid capital loss. Liquidity risks may prevent exiting trades at desired prices. This AI-generated analysis is for educational purposes only and is not financial advice. Generated on September 26, 2026.Growth of $10,000
A $10,000 investment in CRM in September 2016 would be worth about $33,341 today, compared with about $36,004 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CRM today could grow to about $25,781 by 2036 in the base case, with a bull case near $112,744 and a bear case around $5,895. Projections are statistical simulations, not guarantees.
CRM Stock Price Prediction: 2030
CleaRank's simulation projects a price near $342 for CRM by 2030 in the base case, from $234 today (1.5x over 4 years). The downside path ends near $134. These are outcomes of a Monte Carlo simulation run on CRM's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $161 | $257 | $410 |
| 2028 | $146 | $283 | $547 |
| 2029 | $139 | $311 | $698 |
| 2030 | $134 | $342 | $869 |
| 2031 | $132 | $376 | $1,067 |
| 2032 | $132 | $413 | $1,295 |
| 2033 | $132 | $454 | $1,561 |
| 2034 | $133 | $499 | $1,868 |
| 2035 | $135 | $549 | $2,225 |
| 2036 | $138 | $603 | $2,638 |
Method: 10,000 simulated price paths using CRM's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
CRM Insider Trading Analysis
Bought
$28.4M
6 Transactions
Sold
$95.9M
108 Transactions
Insiders
24
Active Traders
Avg Transaction
$1.1M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Dec 20, 2024 | MORFIT G MASON
Director
|
Sell | 1.0M | $350.0M |
| Dec 29, 2023 | BENIOFF MARC RUSSELL
Chief Executive Officer
|
Sell | 530.0K | $140.4M |
| Dec 18, 2024 | BENIOFF MARC RUSSELL
Chief Executive Officer
|
Sell | 317.1K | $110.0M |
| Jun 14, 2023 | BENIOFF MARC RUSSELL
Chief Executive Officer
|
Sell | 500.0K | $104.6M |
| Jan 19, 2024 | MILLHAM BRIAN
President
|
Sell | 294.0K | $82.3M |
| Dec 23, 2024 | TALLAPRAGADA SRINIVAS
President
|
Sell | 174.1K | $59.1M |
| Jun 29, 2022 | BENIOFF MARC RUSSELL
Chief Executive Officer
|
Sell | 302.3K | $53.0M |
| Jun 30, 2022 | BENIOFF MARC RUSSELL
Chief Executive Officer
|
Sell | 302.3K | $51.5M |
| Jun 5, 2023 | TALLAPRAGADA SRINIVAS
President
|
Sell | 150.3K | $31.7M |
| Dec 2, 2025 | HARRIS G PARKER
Officer and Director
|
Sell | 134.7K | $31.6M |
Page 1 of 1
Frequently Asked Questions
Is Salesforce, Inc. (CRM) stock a buy right now?
Salesforce, Inc. (CRM) is currently rated a 'Buy' with a consensus score of 69 out of 100. The median analyst price target is $285.00, offering a 21.8% upside from the current price of $234.02. However, significant insider selling should be monitored.
What is CRM's price prediction for 2030?
Based on Monte Carlo simulations, Salesforce, Inc. (CRM) has a base case price projection of $341.80 for 2030, with a downside scenario of $134.43 and an upside scenario of $869.05. These are statistical outcomes, not guarantees.
How has Salesforce performed in recent earnings reports?
Salesforce, Inc. (CRM) has a strong history of earnings beats, most recently reporting an EPS of $5.90 for the quarter ending September 2026, significantly exceeding the estimate of $3.27 and leading to a 22.58% stock price increase.
What are the key risks for Salesforce stock?
The primary risks for Salesforce, Inc. (CRM) include significant insider selling totaling $95.9 million, bearish short-term momentum indicated by the RSI, and ongoing competitive pressures within the software application sector.
How does Salesforce's valuation compare to its sector peers?
Salesforce, Inc. (CRM) has a P/E ratio of 21.41, which is below the Technology sector median of 34, suggesting it may be undervalued relative to its peers. Its return on equity of 19.38% also outperforms the sector average.
What is the Wall Street consensus for Salesforce stock?
Wall Street analysts maintain a 'Buy' consensus for Salesforce, Inc. (CRM), with 55 analysts covering the stock. The median price target is $285.00, indicating a potential 21.8% upside from the current price.
What is Salesforce's revenue growth outlook?
Salesforce, Inc. (CRM) is expected to achieve revenue growth of approximately 12.00% for the current quarter and 11.00% for the current year, indicating continued expansion in its top line.